WHO2023EN
Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders
Zusammenfassung
Mental Health Gap Action
Programme (mhGAP)
guideline for mental,
neurological and
substance use disorders
Mental Health Gap Action
Programme (mhGAP)
guideline for mental,
neurological and
substance use disorders
Design and layout: Green Ink Publishing Services Ltd
Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders
This publication is the update of the documents published in 2010 entitled “mhGAP intervention guide for mental,
Kerninformationen
slation. The original English edition shall be the binding
and authentic edition”.
Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the
World Intellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules/).
...
ce to others of a similar nature that are not mentioned. Errors and omissions excepted, the
names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the
published ...
ist of essential medicines (EML) 112
5. Monitoring and evaluating the impact of the guideline 113
6. Updating the evidence 114
References 115
Annex 1. Contributors to the guideline 130
Annex 2. Managing declarations of interest and conflicts of interest 145
v
Acknowledgements
This World ...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
WHO2013
Guidelines for the management of conditions that are specifically related to stress
WHO2023
WHO Mental Health Gap Action Programme (mhGAP) Guidelines
WHO2016
WHO mhGAP Intervention Guide for Mental Health (Version 2.0)
SIGN2013
SIGN 131: Management of schizophrenia
WHO2022
Guidelines on mental health at work
WHO2022
WHO Guidelines on Mental Health at Work
Cochrane2020
Cochrane Review: Behavioural activation therapy for depression in adults with non-communicable diseases
Cochrane2024